Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04696653
Other study ID # IRB00269855
Secondary ID P50MH115842
Status Completed
Phase N/A
First received
Last updated
Start date February 24, 2021
Est. completion date April 5, 2023

Study information

Verified date December 2023
Source Johns Hopkins University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This pilot study will examine whether an implementation strategy will improve delivery of evidence-based care for cardiovascular risk factors for people with serious mental illness.


Description:

In this pilot study, the investigators will work with health home programs and pilot test an adapted Comprehensive Unit Safety Program (CUSP) implementation strategy to improve mental health providers' delivery of evidence-based cardiovascular risk factor care for hypertension, dyslipidemia and diabetes for individuals with serious mental illness. The project will also characterize implementation processes, organizational and provider-level factors, and cardiovascular disease risk factor care and control.


Recruitment information / eligibility

Status Completed
Enrollment 628
Est. completion date April 5, 2023
Est. primary completion date November 21, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: Study population 1: - Psychiatric rehabilitation program and health home team staff, including providers and leadership are those employed by the psychiatric rehabilitation program or health home program. - English-speaking. Study population 2: - People with serious mental illness participating in psychiatric rehabilitation health home programs. - English-speaking Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Comprehensive Unit Based Safety Program (CUSP)
CUSP is a quality improvement strategy developed by the Johns Hopkins University Armstrong Institute for Patient Safety and Quality that is used to improve care delivery.

Locations

Country Name City State
United States Johns Hopkins Adult Psychiatric Rehabilitation Program Baltimore Maryland

Sponsors (2)

Lead Sponsor Collaborator
Johns Hopkins University National Institute of Mental Health (NIMH)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in quality improvement culture as assessed by the modified version of the validated Survey on Patient Safety Each of the 34 items in the modified survey is scored individually on 1-5 Likert scales. An average score is calculated by summing responses across all 34 items and dividing by the total number of items. The average score ranges from 1-5. A higher average score signifies an organizational culture that is more supportive of quality improvement. Baseline, 12 months
Primary Change in self-efficacy as assessed by an adapted version of Compeau & Higgins' task-focused self-efficacy scale Each of the nine items is scored individually on a 1-10 Likert scale, where 1=not at all confident and 10=totally confident. An average score is calculated by summing responses across all 9 items and dividing by the total number of items. The average score ranges from 1-10. A higher score signifies greater self-efficacy. Baseline, 12 months
Secondary Change in acceptability as assessed by the Acceptability of Intervention Measure We will use a validated 4-item instrument measuring intervention acceptability, using the Acceptability of Intervention Measure. Each of the 4 items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater acceptability. Baseline, 12 months
Secondary Change in appropriateness as assessed by the Intervention Appropriateness Measure We will use a validated 4-item instrument measuring intervention appropriateness, using the Intervention Appropriateness Measure. Each of the 4 items will be measured on a 5-point Likert scale, where 1=completely disagree and 5= completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater appropriateness. Baseline, 12 months
Secondary Change in feasibility as assessed by the Feasibility of Intervention Measure We will use a validated 4-item instrument measuring intervention feasibility, using the Feasibility of Intervention Measure. Each of the 4 items will be measured on a 5-point Likert scale, where 1=completely disagree and 5=completely agree. An average score is calculated by summing responses across all four items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater feasibility. Baseline, 12 months
Secondary Change in Hypertension control Measured with blood pressure (BP) readings (Controlled BP defined as <130/80 mmHg). Baseline, 6 and 12 months
Secondary Change in dyslipidemia control Measured with cholesterol readings (controlled dyslipidemia defined as total cholesterol <200 mg/dL and low-density lipoprotein (LDL) <130 mg/dL). Baseline, 6 and 12 months
Secondary Change in diabetes control Measured using HbA1c tests (controlled diabetes defined as HbA1c<7.0). Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received HBA1c measurement Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received a lipid panel Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received statin therapy Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received a dilated eye exam Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received a foot exam Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with dyslipidemia who received a lipid panel Baseline, 6 and 12 months
Secondary Change in teamwork within units as assessed by the modified version of the validated Survey on Patient Safety We will use 4 items measuring teamwork. Each of the 4 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better teamwork within units. Baseline, 12 months
Secondary Change in supervisor promotion of quality improvement as assessed by the modified version of the validated Survey on Patient Safety We will use 4 items measuring the degree to which a provider's supervisor promotes quality improvement. Each of the 4 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater promotion of quality improvement. Baseline, 12 months
Secondary Change in organizational learning as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items measuring organizational learning environment. Each of the 3 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater organizational learning. Baseline, 12 months
Secondary Change in management support for quality improvement as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items measuring the degree to which organization management supports quality improvement. Each of the 3 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies greater management support for quality improvement. Baseline, 12 months
Secondary Change in overall perceptions of quality improvement culture as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items measuring the perception's of the organization's quality improvement culture. Each of the 3 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better quality improvement culture. Baseline, 12 months
Secondary Change in feedback and communication as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items measuring feedback and communication about quality improvement. Each of the 3 items will be measured on a 5-point Likert scale, where 1=never and 5=always. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better feedback and communication. Baseline, 12 months
Secondary Change in communication openness as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items measuring perceptions of communication openness in the organization. Each of the 3 items will be measured on a 5-point Likert scale, where 1=never and 5=always. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better communication openness. Baseline, 12 months
Secondary Change in mistake reporting as assessed by the modified version of the validated Survey on Patient Safety We will use 3 items assessing the degree to which mistakes are reported at the organization. Each of the 3 items will be measured on a 5-point Likert scale, where 1=never and 5=always. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies more frequent mistake reporting. Baseline, 12 months
Secondary Change in teamwork across units as assessed by the modified version of the validated Survey on Patient Safety We will use 4 items assessing teamwork across units. Each of the 4 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better teamwork across units. Baseline, 12 months
Secondary Change in staffing capacity as assessed by the modified version of the validated Survey on Patient Safety We will use 2 items assessing staffing capacity. Each of the 2 items will be measured on a 5-point Likert scale, where 1=strongly disagree and 5=strongly agree. An average score is calculated by summing responses across items and dividing by the total number of items. The average score ranges from 1-5. A higher score signifies better staffing capacity. Baseline, 12 months
Secondary Change in the percent of individuals with systolic blood pressure with poorly controlled hypertension who had a blood pressure measurement Measured with blood pressure (BP) readings (Poorly controlled BP defined as >130/80 mmHg). Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received a urine-protein-creatinine test Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with dyslipidemia who are on a statin medication Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with hypertension who received lifestyle counseling Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with diabetes mellitus who received lifestyle counseling Baseline, 6 and 12 months
Secondary Change in the percent of individuals diagnosed with dyslipidemia who received lifestyle counseling Baseline, 6 and 12 months
See also
  Status Clinical Trial Phase
Terminated NCT04591808 - Efficacy and Safety of Atorvastatin + Perindopril Fixed-Dose Combination S05167 in Adult Patients With Arterial Hypertension and Dyslipidemia Phase 3
Recruiting NCT04515303 - Digital Intervention Participation in DASH
Completed NCT05433233 - Effects of Lifestyle Walking on Blood Pressure in Older Adults With Hypertension N/A
Completed NCT05491642 - A Study in Male and Female Participants (After Menopause) With Mild to Moderate High Blood Pressure to Learn How Safe the Study Treatment BAY3283142 is, How it Affects the Body and How it Moves Into, Through and Out of the Body After Taking Single and Multiple Doses Phase 1
Completed NCT03093532 - A Hypertension Emergency Department Intervention Aimed at Decreasing Disparities N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Completed NCT05529147 - The Effects of Medication Induced Blood Pressure Reduction on Cerebral Hemodynamics in Hypertensive Frail Elderly
Recruiting NCT06363097 - Urinary Uromodulin, Dietary Sodium Intake and Ambulatory Blood Pressure in Patients With Chronic Kidney Disease
Recruiting NCT05976230 - Special Drug Use Surveillance of Entresto Tablets (Hypertension)
Completed NCT06008015 - A Study to Evaluate the Pharmacokinetics and the Safety After Administration of "BR1015" and Co-administration of "BR1015-1" and "BR1015-2" Under Fed Conditions in Healthy Volunteers Phase 1
Completed NCT05387174 - Nursing Intervention in Two Risk Factors of the Metabolic Syndrome and Quality of Life in the Climacteric Period N/A
Completed NCT04082585 - Total Health Improvement Program Research Project
Recruiting NCT05121337 - Groceries for Black Residents of Boston to Stop Hypertension Among Adults Without Treated Hypertension N/A
Withdrawn NCT04922424 - Mechanisms and Interventions to Address Cardiovascular Risk of Gender-affirming Hormone Therapy in Trans Men Phase 1
Active, not recruiting NCT05062161 - Sleep Duration and Blood Pressure During Sleep N/A
Completed NCT05087290 - LOnger-term Effects of COVID-19 INfection on Blood Vessels And Blood pRessure (LOCHINVAR)
Not yet recruiting NCT05038774 - Educational Intervention for Hypertension Management N/A
Completed NCT05621694 - Exploring Oxytocin Response to Meditative Movement N/A
Completed NCT05688917 - Green Coffee Effect on Metabolic Syndrome N/A
Recruiting NCT05575453 - OPTIMA-BP: Empowering PaTients in MAnaging Blood Pressure N/A